Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥18 years of age
COVID-19 infection, confirmed by polymerase chain reaction (PCR) test \<=3 days from enrollment
Require inpatient hospitalization due to COVID-19 with minimal respiratory symptoms
Able to provide informed consent
You may not be if
Unable to take oral medication
Pregnant or breastfeeding
On non-invasive positive pressure ventilation or mechanical ventilation at time of study entry
Requiring ≥6L oxygen or respiratory rate ≥30
Taking bicalutamide, any systemic hormonal therapy, or prophylactic treatment for COVID-19 within one month of study entry
Known hypersensitivity to bicalutamide or its components.
A past medical history of cirrhosis or AST/ALT/Alk phos/bilirubin \> 3x the upper limit of normal
Patients with a clinical history of myocardial infarction or congestive heart failure within 6 months, or with prior echocardiogram showing ejection fraction \< 40%
Patients currently on coumadin anticoagulants due to the potential for drug-drug interactions.
Clareo Health | Trial to Promote Recovery From COVID-19 With Endocrine Therapy
